NASDAQ:IVF

Naya Biosciences . Common Stock Stock Forecast

etoro logo Buy IVF
*Your capital is at risk
$1.04
-0.0200 (-1.89%)
At Close: Aug 10, 2026

Should you buy IVF stock?

Last updated:

Based on market data through , StockInvest.us rates Naya Biosciences, Inc. Common Stock (IVF) as a Sell Candidate with a technical score of -1.91 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 23.53%
  • 3-month trend forecast Down 26.49%
  • Sell Candidate -1.91
AI Analysis AI Analysis of IVF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IVF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Naya Biosciences, Inc. Common Stock
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 06, 2026 Loss -23.53%

The Naya Biosciences, Inc. Common Stock stock price fell by -1.89% on the last day (Monday, 10th Aug 2026) from $1.06 to $1.04. During the last trading day the stock fluctuated 3.35% from a day low at $1.04 to a day high of $1.07. The price has risen in 6 of the last 10 days and is up by 8.43% over the past 2 weeks. Volume has increased on the last day by 45 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 64 thousand shares were bought and sold for approximately $66.09 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.81 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -26.49% during the next 3 months and, with a 90% probability hold a price between $0.598 and $1.53 at the end of this 3-month period.

IVF Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 14.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Naya Biosciences, Inc. Common Stock stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.23. On a fall, the stock will find some support from the short-term average at $1.03. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Naya Biosciences, Inc. Common Stock gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Naya Biosciences, Inc. Common Stock stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.98 and $0.96. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Naya Biosciences, Inc. Common Stock finds support just below today's level at $0.98. If this is broken, then the next support from accumulated volume will be at $0.96 and $0.94.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0347 between high and low, or 3.35%. For the last week, the stock has had daily average volatility of 7.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IVF) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Naya Biosciences, Inc. Common Stock to open at $1.05, and during the day (based on 14 day Average True Range), to move between $0.98 and $1.10, which gives a possible trading interval of +/-$0.117 (+/-11.92%) up or down from last closing price. If Naya Biosciences, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 11.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.98 (5.78%) than the resistance at $1.13 (8.65%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Naya Biosciences, Inc. Common Stock stock A Buy?

Naya Biosciences, Inc. Common Stock holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.908 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.05 ( 0.80%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IVF Performance

Trading levels for IVF

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.08 4.14%
R2 1.07 2.87%
R1 1.06 2.08%
Price 1.04
S1 1.04 -0.470%
S2 1.03 -1.26%
S3 1.01 -2.53%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.24 19.23%
R2 1.16 11.54%
R1 1.13 8.65%
Price 1.04
S1 0.98 -5.78%
S2 0.96 -7.78%
S3 0.94 -9.63%

FAQ

What is the symbol for Naya Biosciences, Inc. Common Stock Stock and on which exchange is it traded?
The symbol for Naya Biosciences, Inc. Common Stock is IVF and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Naya Biosciences, Inc. Common Stock Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Naya Biosciences, Inc. Common Stock (IVF) as a Sell Candidate with a technical score of -1.91 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 06, 2026, the price has fallen 23.53%. The current 3-month trend forecast projects a fall of 26.49%.

How to buy Naya Biosciences, Inc. Common Stock Stock?
Naya Biosciences, Inc. Common Stock Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Naya Biosciences, Inc. Common Stock Stock.

What's the current price of Naya Biosciences, Inc. Common Stock Stock?
As of the end of day on the Aug 10, 2026, the price of an Naya Biosciences, Inc. Common Stock (IVF) share was $1.04.

What is the 52-week high and low for Naya Biosciences, Inc. Common Stock Stock?
The 52-week high for Naya Biosciences, Inc. Common Stock Stock is $13.08 and the 52-week low is $0.90.

What is the market capitalization of Naya Biosciences, Inc. Common Stock Stock?
As of the Aug 10, 2026, the market capitalization of Naya Biosciences, Inc. Common Stock is 1.857M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE